A practical reference on Cardarine: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-07-23 and is reviewed periodically as new material appears.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human therapeutic use | No marketing authorization identified in major jurisdictions. |
| Anti-doping class | PPARδ agonist; hormone and metabolic modulators | Listed on the WADA Prohibited List. |
| Common test matrix | Urine | Also blood and tissue in research settings. |
| Typical analytical method | LC-MS/MS | Targets parent compound and metabolites. |
| Major safety signal | Tumor findings in rodents | Human relevance not established; limited human data. |
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
==== Inhibition ==== Factors from the lining of vessels stop platelets from activating. An intact endothelial lining inhibits platelet activation by producing nitric oxide, endothelial-ADPase, and PGI2 (prostacyclin). Endothelial-ADPase degrades the platelet activator ADP. Resting platelets maintain active calcium efflux via a cyclic AMP-activated calcium pump. Intracellular calcium concentration determines platelet activation status, as it is the second messenger that drives platelet conformational change and degranulation. Endothelial prostacyclin binds to prostanoid receptors on the surface of resting platelets. This event stimulates the coupled Gs protein to increase adenylate cyclase activity and increases the production of cAMP, further promoting the efflux of calcium and reducing intracellular calcium availability for platelet activation. ADP binds to purinergic receptors on the platelet surface. Since the thrombocytic purinergic receptor P2Y12 is coupled to Gi proteins, ADP reduces platelet adenylate cyclase activity and cAMP production, leading to accumulation of calcium inside the platelet by inactivating the cAMP calcium efflux pump. The other ADP-receptor P2Y1 couples to Gq that activates phospholipase C-beta 2 (PLCB2), resulting in inositol 1,4,5-trisphosphate (IP3) generation and intracellular release of more calcium. This together induces platelet activation. Endothelial ADPase degrades ADP and prevents this from happening. Clopidogrel and related antiplatelet medications also work as purinergic receptor P2Y12 antagonists.
The growing number of smart ports around the world are increasing capacity and efficiency for shippers, ports, and freight forwarding partners, such as trucking carriers. Reductions in labour and machinery costs can be seen at ports thanks to improvements in automated and semi-automated cranes, which reduce the need for yard transfer vehicles. In 2018, shipping conglomerate Maersk partnered with IBM to create TradeLens, a platform for sharing and streamlining shipping information across shipping partners, businesses, and different authorities. By 2019, the platform covered nearly half of the world’s shipments of cargo containers.
Quantitative characters are morphological features that can be counted or measured for example a plant species has flower petals 10–12 mm wide. Qualitative characters are morphological features such as leaf shape, flower color or pubescence. Both kinds of characters can be very useful for the identification of plants.
Sources: en.wikipedia.org
BSA can be calculated on the basis of weight and height. Twenty-four-hour urine collection to assess creatinine clearance is no longer widely performed, due to difficulty in assuring complete specimen collection. To assess the adequacy of a complete collection, one always calculates the amount of creatinine excreted over a 24-hour period. This amount varies with muscle mass and is higher in young people/old, and in men/women. An unexpectedly low or high 24-hour creatinine excretion rate voids the test. Nevertheless, in cases where estimates of creatinine clearance from serum creatinine are unreliable, creatinine clearance remains a useful test. These cases include "estimation of GFR in individuals with variation in dietary intake (vegetarian diet, creatine supplements) or muscle mass (amputation, malnutrition, muscle wasting), since these factors are not specifically taken into account in prediction equations." A number of formulae have been devised to estimate GFR or Ccr values on the basis of serum creatinine levels. Where not otherwise stated serum creatinine is assumed to be stated in mg/dL, not μmol/L—divide by 88.4 to convert from μmol/Lto mg/dL.
This article records new taxa of fossil mammals of every kind that are scheduled to be described during the year 2026, as well as other significant discoveries and events related to paleontology of mammals that are scheduled to occur in the year 2026.
Mei Hong (born 1970) is a Chinese-American biophysical chemist and professor of chemistry at the Massachusetts Institute of Technology. She is known for her creative development and application of solid-state nuclear magnetic resonance (ssNMR) spectroscopy to elucidate the structures and mechanisms of membrane proteins, plant cell walls, and amyloid proteins. She has received a number of recognitions for her work, including the American Chemical Society Nakanishi Prize in 2021, Günther Laukien Prize in 2014, the Protein Society Young Investigator award in 2012, and the American Chemical Society’s Pure Chemistry award in 2003.
Malacidins are a class of chemicals made by bacteria found in soil that can kill Gram-positive bacteria. Their activity appears to be dependent on calcium. The discovery of malacidins was published in 2018. The malacidin family were discovered using a new method of soil microbiome screening that does not require cell culturing. This allowed researchers to identify genetic components necessary to produce the chemical. Malacidin A was shown to kill Staphylococcus aureus and other Gram-positive bacteria. At the time of publication it was not certain if the discovery would lead to any new antibiotic drugs, because large investments of time and money are required to determine whether any drug is safe and effective.
Sources: en.wikipedia.org
=== First combat operations === The ENT participated in its first major combat operations in June–July 1977, against Libyan-supported FROLINAT rebels. Following an attack on Zouar, reconnaissance missions were launched from the Faya-Largeau Airport. The first attack sorties were flown by Skyraiders on 1 July. Bombs, rockets and cannons were used against the rebel positions, but nearly every aircraft involved was damaged by ground fire. The next day, tactics were changed, with the pilots deciding to attack from altitudes as low as 60 m, releasing all of their weapons in a single pass. Even though the exposure to return fire was reduced, several aircraft were damaged by the explosions of bombs and rockets. On 3 July, a Skyraider received a hit in its engine, and its pilot was forced to land on an abandoned airstrip near Zouar. He was quickly recovered by his wingman. A team of technicians later arrived on board a C-47, and repaired the aircraft, which was flown out the next day. Despite the ENT's efforts, Zouar was overrun by the FROLINAT on 6 July. Following several months of preparations, the FROLINAT's next major attack came in January 1978. All of the ANT's garrisons in the Tibesti were overrun. The FROLINAT and the Libyan Army's advance was monitored by the ENT. During one of such missions, on 29 January, a C-47 was hit by a 9K32 Strela-2 (SA-7) MANPADS while flying at a very low altitude, and it crashed; its whole crew was killed.
== Elements considered possibly essential for humans but not confirmed == Many ultratrace elements have been suggested as essential, but such claims have usually not been confirmed. Definitive evidence for efficacy comes from the characterization of a biomolecule containing the element with an identifiable and testable function. One problem with identifying efficacy is that some elements are innocuous at low concentrations and are pervasive (examples: silicon and nickel in solid and dust), so proof of efficacy is lacking because deficiencies are difficult to reproduce. Some elements were once thought to have a role with unknown biochemical nature, but the evidence has not always been strong. For example, it was once thought that arsenic was probably essential in mammals, but it seems to be only used by microbes; and while chromium was long thought to be an essential trace element based on rodent models, and was proposed to be involved in glucose and lipid metabolism, more recent studies have called this into question. It may still have a role in insulin signalling, but the evidence is not clear, and it only seems to occur at doses not found in normal diets. Boron is essential to plants, but not humans, although depletion-repletion studies in humans showed benefits to bone and brain health. Non-essential elements can sometimes appear in the body when they are chemically similar to essential elements (e.g. Rb+ and Cs+ replacing Na+), so that essentiality is not the same thing as uptake by a biological system.
That same day, Peru and the OAS signed a joint declaration in favor of democracy and human rights. The OAS leader Luis Almagro said that "We have seen that president Castillo has much determination to fight corruption, especially corruption that may appear in his government. Let his management be as clean as possible. This requires important efforts in investigation. Let there be a permanent monitoring of transparency, of justice, so that there isn't any element of shadow over official members." On 5 December, Cuarto Poder finally released the audio clip. The audio showed the owner of the Breña house offering "scoops and headlines" to a journalist in exchange for the journalist shelving an unfavorable news story. The host of ATV news, Juliana Oxenford, claimed that it is "much more revealing to know the high content of trans fats in Cheese Tris than the audio of Cuarto Poder." Meanwhile, the journalist Juan Carlos Tafur said that the Cuarto Poder audio "qualifies as a journalistic scam." Following the release of the Cuarto Poder clips, the impeachment motion rapidly fell apart as less hardline members of the opposition rescinded their support for the impeachment motion. On 7 December 2021, with 46 in favor, 76 against, and 4 abstentions, Congress refused to admit the impeachment motion. Following the defeat of the impeachment motion, President Castillo said: "I am grateful that the congressional voted to put Peru first before other interests."
Sources: en.wikipedia.org
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.
It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.
Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.